Inhibition of angiogenesis by rhizoxin, a microbial metabolite containing two epoxide groups

Japanese Journal of Cancer Research

Volumn 88, Issue 12, 1997, Pages 1125-1129

  Onozawa, Chizuko ^a,c   Shimamura, Mariko ^a   Iwasaki, Shigeo ^b,d   Oikawa, Tsutomu ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^d KITASATO INSTITUTE   (Japan)

Author keywords

Angiogenesis; Angiogenesis inhibitor; Angiostatic therapy; Epoxide group; Rhizoxin

Indexed keywords

15 DEOXYSPERGUALIN; 22 OXACALCITRIOL; ANGIOGENESIS INHIBITOR; CALCITRIOL; DEPUDECIN; EPOXIDE; HERBIMYCIN A; RETINOIC ACID; RHIZOXIN; STAUROSPORINE; UNCLASSIFIED DRUG; WORTMANNIN;

AIR SAC; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CHICK EMBRYO; CHORIOALLANTOIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; DRUG STRUCTURE; EMBRYO; EMBRYO DEVELOPMENT; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; TUMOR CELL;

EID: 0031460435     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1997.tb00339.x     Document Type: Article

References (29)

1. Folkman, J. and Shing, Y. Angiogenesis. J. Biol. Chem., 267, 10931-10934 (1992).
2. Folkman, J. Clinical applications of research on angiogenesis. N. Engl. J. Med., 333, 1757-1763 (1995).
3. Herblin, W. F., Brem, S., Fan, T.-P. and Gross, J. L. Recent advances in angiogenesis inhibitors. Exp. Opin. Ther. Patents, 4, 641-654 (1994).
4. Hawkins, M. J. Clinical trials of antiangiogenic agents. Curr. Opin. Oncol., 7, 90-93 (1995).
5. Oikawa, T. Strategies to find novel angiogenesis inhibitors as potential therapeutic agents for cancer. Curr. Med. Chem., 1, 406-407 (1995).
6. Oikawa, T., Hasegawa, M., Shimamura, M., Ashino, H., Murota, S. and Morita, I. Eponemycin, a novel antibiotic, is a highly powerful angiogenesis inhibitor. Biochem. Biophys. Res. Commun., 181, 1070-1076 (1991).
7. Oikawa, T., Ito, H., Ashino, H., Toi, M., Tominaga, T., Morita, I. and Murota, S. Radicicol, a microbial cell differentiation modulator, inhibits in vivo angiogenesis. Eur. J. Pharmacol., 241, 221-227 (1993).
8. Oikawa, T., Onozawa, C., Inose, M. and Sasaki, M. Depudecin, a microbial metabolite containing two epoxide groups, exhibits anti-angiogenic activity in vivo. Biol. Pharm. Bull., 18, 1305-1307 (1995).
9. Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H. and Folkman, J. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature, 348, 555-557 (1990).
10. Otsuka, T., Ohkawa, T., Shibata, T., Oku, T., Okuhara, M., Terano, H., Kohsaka, M. and Imanaka, H. A new potent angiogenesis inhibitor, FR-118487. J. Microbiol. Biothechnol., 1, 163-168 (1991).
11. Corey, E. J., Guzman-Perez, A. and Noe, M. C. Short enantioselective synthesis of (-)-ovalicin, a potent inhibitor of angiogenesis, using substrate-enhanced catalytic asymmetric dihydroxylation. J. Am. Chem. Soc., 116, 12109-12110 (1994).
12. Takahashi, M., Iwasaki, S., Kobayashi, H., Okuda, S., Murai, T., Sato, Y., Haraguchi-Hiraoka, T. and Nagano, H. Studies on macrocyclic lactone antibiotics. XI. Antimitotic and anti-tubulin activity of new antitumor antibiotics, rhizoxin and its homologues. J. Antibiot. (Tokyo), 40, 66-72 (1987).
13. Fotsis, T., Zhang, Y., Pepper, M. S., Adlercreutz, H., Montesano, R., Nawroth, P. P. and Schweigerer, L. The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature, 368, 237-239 (1994).
14. Oliver, S. J., Banquerigo, M. L. and Brahn, E. Suppression of collagen-induced arthritis using an angiogenesis inhibitor, AGM-1470, and a microtubule stabilizer, taxol. Cell. Immunol., 157, 291-299 (1994).
15. Zimrin, A. B., Villeponteau, B. and Maciag, T. Models of in vitro angiogenesis: endothelial cell differentiation on fibrin but not Matrigel is transcriptionally dependent. Biochem. Biophys. Res. Commun., 213, 630-638 (1995).
16. Iwasaki, S., Kobayashi, H., Furukawa, J., Namikoshi, M., Okuda, S., Sato, Z., Matsuda, I. and Noda, T. Studies on macrocyclic lactone antibiotics. VII. Structure of a phytotoxin rhizoxin produced by Rhizopus chinensis. J. Antibiot. (Tokyo), 37, 354-362 (1984).
17. Oikawa, T., Hirotani, K., Nakamura, O., Shudo, K., Hiragun, A. and Iwaguchi, T. A highly potent antiangiogenic activity of retinoids. Cancer Lett, 48, 157-162 (1989).
18. Oikawa, T., Sasaki, M., Inose, M., Shimamura, M., Kuroki, H., Hirano, S., Kumagai, H., Ishizuka, M. and Takeuchi, T. Effect of cytogenin, a novel microbial product, on embryonic and tumor cell-induced angiogenic responses in vivo. Anticancer Res., 17, 1881-1886 (1997).
19. Sidky, Y. A. and Borden, E. C. Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses. Cancer Res., 47, 5155-5161 (1987).
20. Plunkett, M. L. and Hailey, J. A. An in vivo quantitative angiogenesis model using tumor cells entrapped in alginate. Lab. Invest., 62, 510-517 (1990).
21. Majewski, S., Szmurlo, A., Marczak, M., Jablonska, S. and Bollag, W. Synergistic effect of retinoids and interferon a on tumor-induced angiogenesis: anti-angiogenic effect on HPV-harboring tumor-cell lines. Int. J. Cancer, 57, 81-85 (1994).
22. Oikawa, T., Okayasu, I., Ashino, H., Morita, I., Murota, S. and Shudo, K. Three novel synthetic retinoids, Re 80, Am 580 and Am 80, all exhibit anti-angiogenic activity in vivo. Eur. J. Pharmacol., 249, 113-116 (1993).
23. 3 analogues. Eur. J. Pharmacol., 178, 247-250 (1990).
24. Oikawa, T., Shimamura, M., Ashino-Fuse, H., Iwaguchi, T., Ishizuka, M. and Takeuchi, T. Inhibition of angiogenesis by 15-deoxyspergualin. J. Antibiot. (Tokyo), 44, 1033-1035 (1991).
25. Sugino, E., Fujimori, S., Hibino, S., Choshi, T., Ichihara, Y., Sato, Y., Yamaji, T., Tsuboi, H., Murata, N., Uchida, M., Shimamura, M. and Oikawa, T. Synthesis of a new potent anti-angiogenic agent, 17α-acetoxy-9α-fluoro-6α-methylprogesterone (9α-fluoromedroxyprogesterone acetate [FMPA]). Chem. Pharm. Bull., 45, 421-423 (1997).
26. Oikawa, T. and Shimamura, M. Potent inhibition of angiogenesis by wortmannin, a fungal metabolite. Eur. J. Pharmacol., 318, 93-96 (1996).
27. Hart, I. R., Talmadge, J. E. and Fiedler, I. J. Metastatic behavior of a murine reticulum cell sarcoma exhibiting organ-specific growth. Cancer Res., 41, 1281-1287 (1981).
28. Tanaka, N. G., Sakamoto, N., Inoue, K., Korenaga, H., Kadoya, S., Ogawa, H. and Osada, Y. Antitumor effects of an antiangiogenic polysaccharide from an Arthrobacter species with or without a steroid. Cancer Res., 49, 6727-6730 (1989).
29. Kiue, A., Abe, T., Morimoto, A., Okamura, K., Ono, M., Kohno, K., Oikawa, T., Iwaguchi, T., Ishizuka, M., Takeuchi, T. and Kuwano, M. Anti-angiogenic effect of 15-deoxyspergualin in angiogenesis model system involving human microvascular endothelial cells. Cancer J., 5, 267-271 (1992).